Press Releases | Medtronic

Month Year

Email alerts

Feb 27, 2013

Meta-Analysis Demonstrates Efficacy of Pillar Procedure for the Treatment of Snoring and Mild to Moderate Obstructive Sleep Apnea

Authors Reach Conclusions After a Meta-Analysis of 7 Clinical Studies for Snoring, and 7 Studies for OSA

MINNEAPOLIS - Feb. 27, 2013 - In a meta-analysis of seven studies published in the January issue of Laryngoscope, Ji Ho Choi, M.D., Ph. D., and coauthors conclude that the Medtronic Pillar...
Feb 26, 2013

Medtronic Gains First FDA Approval to Conduct Early Feasibility Medical Device Study

Shared Commitment to Innovation Enables Early Study of Novel Native Outflow Tract Transcatheter Pulmonary Valve in Patients with Pulmonary Valve Failure

MINNEAPOLIS - February 26, 2013 - Medtronic, Inc. (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval to conduct an early feasibility study using the...
Feb 25, 2013

FDA Approves Longer Lengths of Medtronic's Resolute Integrity Stent

New Sizes of Implantable Medical Device Target Long Coronary Lesions Common Among Diabetes Patients

MINNEAPOLIS -- Feb. 25, 2013 -- Expanding the applicability of its marquee product for the interventional treatment of coronary artery disease in the United States, Medtronic, Inc. (NYSE: MDT)...
Feb 25, 2013

Medtronic CFO Gary Ellis to Speak at Citi Global Healthcare Conference

MINNEAPOLIS - Feb. 25, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Citi Global Healthcare Conference on...
Feb 19, 2013

Medtronic Reports Third Quarter Earnings

Revenue of $4.0 Billion Grew 4% on a Constant Currency Basis; 3% as Reported

MINNEAPOLIS - February 19, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2013, which ended January 25, 2013. The Company reported...
Feb 14, 2013

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2013

MINNEAPOLIS - February 14, 2013 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.26 per share of the Company's common stock. The dividend is payable on...
Feb 13, 2013

Medtronic Announces FDA Approval and Launch of Its Advisa MRI Pacemaker System

Second-generation MR-Conditional Pacemaker Combines Advanced Pacing Technology with MRI Access

MINNEAPOLIS - February 13, 2013 - Showcasing its leadership position in pacing technologies, Medtronic, Inc. (NYSE: MDT), today announced the U.S. Food and Drug Administration (FDA) approval and...
Feb 13, 2013

AIRvance(TM) Bone Screw System Gains Additional FDA Clearance

The AIRvance(TM) Bone Screw System Is Now Suitable for the Performance of a Hyoid Suspension Procedure, Which Can Be Used in Combination with Other Procedures for the Treatment of Obstructive Sleep Apnea

MINNEAPOLIS - Feb. 13, 2013 - Medtronic announced today that it has received Food and Drug Administration (FDA) clearance for its AIRvance(TM) Bone Screw System that allows surgeons to perform a...
Feb 11, 2013

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2013

MINNEAPOLIS - Feb. 11, 2013 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2013 on Tuesday, February 19, 2013. A news...
Feb 5, 2013

Ricky Rubio, La Estrella De Los Minnesota Timberwolves Colabora Con La Fundación Medtronic Para Salvar La Vida De Jóvenes Víctimas De Paro Cardíaco Súbito

Rubio ayuda a los visitantes de la página web a salvar una vida "virtual" en HeartRescueNow.com

MINNEAPOLIS, 5 de febrero, 2013 - Ricky Rubio, la estrella de los Minnesota Timberwolves se une a la fundación Medtronic durante este mes de febrero para salvar la vida de jóvenes de todo el...

Show per page